For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
All the official reform papers, all in one place
All the official reform papers, all in one place

The Government’s “white paper” backgrounder on its health reforms, Our health and disability system - Building a stronger health and disability system for all New Zealanders.
The Cabinet paper: The Health and Disability System Review: Proposals for Reform
Speeches by health minister Andrew Little and associate health minister Peeni Henare at Parliament when announcing the reforms: Health and Disability System Review announcement speeches.
Final report by the review panel, also known as the “Simpson report”: Health and Disability System Review Final Report Pūrongo Whakamutunga.
Interim report by the review panel: Health and Disability System Review Interim Report Pūrongo Mō Tēnei Wā